|Articles|June 8, 2020
Managing the COVID-19 Drug Safety Response
Author(s)MyMeds&Me
Current safety reporting systems cannot meet the demands of a COVID-19 response. Find out how digital transformation enables rapid understanding & management of drug safety.
Trending on PharmExec
1
FDA Pannel Votes to Loosen Restrictions for Four Peptides
2
Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides
3
President Trump Announces Phased Generic Drug Tariff Plan: Report
4
Retatrutide Delivers Up to 22.6% Weight Loss in Two New Phase III Trials
5